JP2013533745A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533745A5 JP2013533745A5 JP2013518791A JP2013518791A JP2013533745A5 JP 2013533745 A5 JP2013533745 A5 JP 2013533745A5 JP 2013518791 A JP2013518791 A JP 2013518791A JP 2013518791 A JP2013518791 A JP 2013518791A JP 2013533745 A5 JP2013533745 A5 JP 2013533745A5
- Authority
- JP
- Japan
- Prior art keywords
- norovirus
- chimeric
- strain
- vlp
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001263478 Norovirus Species 0.000 claims description 74
- 108090000623 proteins and genes Proteins 0.000 claims description 46
- 102000004169 proteins and genes Human genes 0.000 claims description 36
- 210000004027 cell Anatomy 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 14
- 108020004707 nucleic acids Proteins 0.000 claims description 13
- 102000039446 nucleic acids Human genes 0.000 claims description 13
- 150000007523 nucleic acids Chemical class 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 230000002163 immunogen Effects 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 241000271566 Aves Species 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims description 2
- 241000714209 Norwalk virus Species 0.000 claims description 2
- 241000509413 Snow Mountain virus Species 0.000 claims description 2
- 241000223892 Tetrahymena Species 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 210000004962 mammalian cell Anatomy 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36158110P | 2010-07-06 | 2010-07-06 | |
| US61/361,581 | 2010-07-06 | ||
| PCT/US2011/042979 WO2012006293A1 (en) | 2010-07-06 | 2011-07-05 | Norovirus derived immunogenic compositions and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016000962A Division JP6351641B2 (ja) | 2010-07-06 | 2016-01-06 | ノロウイルスに由来する免疫原性組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013533745A JP2013533745A (ja) | 2013-08-29 |
| JP2013533745A5 true JP2013533745A5 (enExample) | 2014-08-14 |
Family
ID=44628871
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518791A Pending JP2013533745A (ja) | 2010-07-06 | 2011-07-05 | ノロウイルスに由来する免疫原性組成物および方法 |
| JP2016000962A Active JP6351641B2 (ja) | 2010-07-06 | 2016-01-06 | ノロウイルスに由来する免疫原性組成物および方法 |
| JP2018030649A Withdrawn JP2018086020A (ja) | 2010-07-06 | 2018-02-23 | ノロウイルスに由来する免疫原性組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016000962A Active JP6351641B2 (ja) | 2010-07-06 | 2016-01-06 | ノロウイルスに由来する免疫原性組成物および方法 |
| JP2018030649A Withdrawn JP2018086020A (ja) | 2010-07-06 | 2018-02-23 | ノロウイルスに由来する免疫原性組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20130171185A1 (enExample) |
| EP (2) | EP3153578A1 (enExample) |
| JP (3) | JP2013533745A (enExample) |
| CN (1) | CN103154242B (enExample) |
| AU (1) | AU2011276328C1 (enExample) |
| CA (1) | CA2804501C (enExample) |
| MX (1) | MX2013000163A (enExample) |
| WO (1) | WO2012006293A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103153284B (zh) | 2010-07-06 | 2015-11-25 | 诺华股份有限公司 | 含有其pKa值有利于RNA递送的脂质的脂质体 |
| SI3243526T1 (sl) | 2010-07-06 | 2020-02-28 | Glaxosmithkline Biologicals S.A. | Dostava RNA za sprožitev večih imunskih poti |
| DK2591114T3 (en) | 2010-07-06 | 2016-08-29 | Glaxosmithkline Biologicals Sa | Immunization of large mammals with low doses of RNA |
| LT4226941T (lt) | 2010-08-31 | 2025-01-10 | Glaxosmithkline Biologicals Sa | Pegilintos liposomos, skirtos imunogeną koduojančios rnr pristatymui |
| BR112013008700B8 (pt) | 2010-10-11 | 2022-10-04 | Novartis Ag | Molécula de rna auto-replicante, partícula de replicon de alfavírus, composição, molécula de dna recombinante, uso da molécula de rna auto-replicante |
| EP3854413A1 (en) * | 2011-07-06 | 2021-07-28 | GlaxoSmithKline Biologicals SA | Immunogenic combination compositions and uses thereof |
| CA2897752A1 (en) * | 2013-01-10 | 2014-07-17 | Novartis Ag | Influenza virus immunogenic compositions and uses thereof |
| WO2014145245A2 (en) * | 2013-03-15 | 2014-09-18 | The University Of North Carolina At Chapel Hill | Methods and compositions for norovirus blockade epitopes |
| US9975923B2 (en) * | 2013-03-15 | 2018-05-22 | The University Of North Carolina At Chapel Hill | Methods and compositions for norovirus blockade epitopes |
| CN106573988A (zh) * | 2014-08-07 | 2017-04-19 | 基亚生物科技股份有限公司 | 病毒样颗粒疫苗 |
| CA2988761A1 (en) * | 2015-06-12 | 2016-12-15 | Vaxart, Inc. | Formulations for small intestinal delivery of rsv and norovirus antigens |
| CN107034198B (zh) * | 2015-07-15 | 2021-03-09 | 长春百克生物科技股份公司 | 一种嵌合诺如病毒p颗粒及其制备和应用 |
| WO2017160124A2 (ko) * | 2016-03-18 | 2017-09-21 | 연세대학교 산학협력단 | 노로 바이러스 백신을 생산하기 위한 재조합 발현 벡터 |
| KR101915740B1 (ko) | 2016-03-18 | 2018-11-06 | (주)인테라 | 목적 단백질의 발현 효율을 증진시키기 위한 신규한 펩타이드 및 이를 포함하는 융합 단백질 |
| WO2017214557A1 (en) | 2016-06-10 | 2017-12-14 | Counsyl, Inc. | Nucleic acid sequencing adapters and uses thereof |
| CA3037366A1 (en) | 2016-09-29 | 2018-04-05 | Myriad Women's Health, Inc. | Noninvasive prenatal screening using dynamic iterative depth optimization |
| US10752946B2 (en) | 2017-01-31 | 2020-08-25 | Myriad Women's Health, Inc. | Methods and compositions for enrichment of target polynucleotides |
| WO2018144216A1 (en) | 2017-01-31 | 2018-08-09 | Counsyl, Inc. | Methods and compositions for enrichment of target polynucleotides |
| WO2018170603A1 (en) | 2017-03-23 | 2018-09-27 | Medicago Inc. | Norovirus fusion proteins and vlps comprising norovirus fusion proteins |
| WO2018175907A1 (en) | 2017-03-24 | 2018-09-27 | Counsyl, Inc. | Copy number variant caller |
| EP3600397A4 (en) * | 2017-03-28 | 2021-01-27 | Children's Hospital Medical Center | NOROVIRUS PARTICLE VACCINES AND THEIR MANUFACTURING AND USE PROCEDURES |
| RU2020116307A (ru) | 2017-11-30 | 2021-12-30 | Медикаго Инк. | Модифицированные белки vp1 норовируса и vlp, содержащие модифицированные белки vp1 норовируса |
| JP6713013B2 (ja) * | 2018-03-06 | 2020-06-24 | 株式会社イーダブルニュートリション・ジャパン | 貝類のノロウイルス不活化方法 |
| EP3821014A4 (en) * | 2018-07-13 | 2022-04-20 | Medicago Inc. | MODIFIED NOROVIRUS VP1 PROTEINS AND VLPS WITH MODIFIED NOROVIRUS VP1 PROTEINS |
| CN113557240B (zh) * | 2019-03-12 | 2025-02-25 | 爱康遗传有限公司 | 具有提高的稳定性的诺如病毒样颗粒 |
| BR112022013537A2 (pt) * | 2020-01-08 | 2022-11-22 | Bharat Biotech Int Ltd | Composições de vacina viral e métodos de preparações das mesmas |
| CN114316033A (zh) * | 2020-09-29 | 2022-04-12 | 香港理工大学深圳研究院 | 一种特异性识别诺如病毒的单克隆抗体及制备方法与应用 |
| CN115161343B (zh) * | 2021-04-01 | 2024-06-04 | 苏州相奕生物技术有限公司 | 一种重组腺病毒表达载体及以其制备的多价诺如病毒疫苗 |
| AU2022379626A1 (en) * | 2021-10-27 | 2024-05-30 | The Trustees Of The University Of Pennsylvania | Norovirus vaccine and methods of use |
| US20250197454A1 (en) * | 2022-03-18 | 2025-06-19 | Denka Company Limited | Virus-like particle containing capsid proteins connected by linker |
| WO2024144272A1 (ko) * | 2022-12-27 | 2024-07-04 | (주)한국바이오셀프 | 노로바이러스 gii mrna를 포함하는 백신 조성물 |
| WO2024144262A1 (ko) * | 2022-12-27 | 2024-07-04 | (주)한국바이오셀프 | 노로바이러스 gi mrna를 포함하는 백신 조성물 |
| CN118126202B (zh) * | 2024-05-07 | 2024-07-30 | 上海瑞宙生物科技有限公司 | 一种诺如病毒类病毒颗粒及其应用 |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3485094D1 (de) | 1983-01-25 | 1991-10-31 | Ciba Geigy Ag | Neue peptidderivate. |
| US6090406A (en) | 1984-04-12 | 2000-07-18 | The Liposome Company, Inc. | Potentiation of immune responses with liposomal adjuvants |
| US5916588A (en) | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| CA1324969C (en) | 1988-05-06 | 1993-12-07 | Jeffrey R. Shuster | High level expression of proteins in yeast |
| NZ230423A (en) | 1988-08-25 | 1993-08-26 | Liposome Co Inc | A dosage form comprising an antigen and a multilamellar liposome comprising dimyristolyphosphatidylcholine (dmpc) and cholesterol |
| US6572862B1 (en) | 1989-11-08 | 2003-06-03 | Baylor College Of Medicine | Methods and reagents to detect and characterize Norwalk and related viruses |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
| DE69327599T2 (de) | 1992-06-25 | 2000-08-10 | Smithkline Beecham Biolog | Adjuvantien enthaltende Impfstoffzusammensetzung |
| AU4851493A (en) | 1992-09-07 | 1994-03-29 | Baylor College Of Medicine | Methods and reagents to detect and characterize norwalk and related viruses |
| WO1994021292A1 (en) | 1993-03-23 | 1994-09-29 | Smithkline Beecham Biologicals (S.A.) | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| GB9326174D0 (en) | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| FR2726003B1 (fr) | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
| AU753688B2 (en) | 1997-03-10 | 2002-10-24 | Ottawa Civic Loeb Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| US6348450B1 (en) | 1997-08-13 | 2002-02-19 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom and uses thereof |
| AU1145699A (en) | 1997-09-05 | 1999-03-22 | Smithkline Beecham Biologicals (Sa) | Oil in water emulsions containing saponins |
| GB9725084D0 (en) | 1997-11-28 | 1998-01-28 | Medeva Europ Ltd | Vaccine compositions |
| HUP0101139A3 (en) | 1997-12-02 | 2003-11-28 | Powderject Vaccines Inc Madiso | Transdermal delivery of particulate vaccine compositions |
| FR2771751B1 (fr) | 1997-12-03 | 2000-05-26 | Assist Publ Hopitaux De Paris | Erythrovirus et ses applications |
| BR9907884A (pt) | 1998-02-12 | 2000-10-24 | American Cyanamid Co | Composição de vacina, processos para gerar uma resposta imune em um antìgeno pneumocócico, para aumentar resposta de ifn-gama em uma vacina pneumocócica, e para gerar anticorpos de fixação complementar para uma resposta protetora a um patógeno, composição imunogênica, e, processo para gerar uma resposta imune em um antìgeno meningocócico |
| US6303114B1 (en) | 1998-03-05 | 2001-10-16 | The Medical College Of Ohio | IL-12 enhancement of immune responses to T-independent antigens |
| AU746163B2 (en) | 1998-04-09 | 2002-04-18 | Smithkline Beecham Biologicals (Sa) | Adjuvant compositions |
| US6562798B1 (en) | 1998-06-05 | 2003-05-13 | Dynavax Technologies Corp. | Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| BRPI9915545B8 (pt) | 1998-10-16 | 2021-05-25 | Glaxosmithkline Biologicals Sa | composição de vacina, processo para preparação da mesma e kit compreendendo dois recipientes. |
| ATE454445T1 (de) | 1998-11-10 | 2010-01-15 | Univ North Carolina | Virusvektoren und verfahren für ihre herstellung und verabreichung. |
| ES2398413T3 (es) | 1999-06-22 | 2013-03-19 | Japan As Represented By Director-General Of National Institute Of Infectious Diseases | Kit de detección de SRSV |
| BR0014285A (pt) | 1999-09-24 | 2002-05-21 | Smithkline Beecham Biolog | Adjuvantes compreendendo um éster ou éter de alquila de polioxietileno e pelo menos um tensoativo não-iÈnico |
| TR200200774T2 (tr) | 1999-09-24 | 2002-08-21 | Smithkline Beecham Biologicals S.A. | Aşılar. |
| AU3108001A (en) | 2000-01-20 | 2001-12-24 | Coley Pharmaceutical Group, Inc. | Immunostimulatory nucleic acids for inducing a th2 immune response |
| JP4860886B2 (ja) | 2000-06-01 | 2012-01-25 | ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 二本鎖パルボウイルスベクター |
| JP4834279B2 (ja) | 2000-06-15 | 2011-12-14 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | Ｈｃｖ抗原／抗体の組合せアッセイ |
| JP2002020399A (ja) | 2000-07-10 | 2002-01-23 | Osaka Prefecture | ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体 |
| ES2298269T3 (es) | 2000-09-26 | 2008-05-16 | Idera Pharmaceuticals, Inc. | Modulacion de la actividad inmunoestimulante de analogos oligonucleotidicos inmunoestimulantes mediante cambios quimicos posicionales. |
| DK1372708T3 (da) | 2001-02-13 | 2008-10-20 | Us Gov Sec Army | Vaccine til transkutan immunisering mod rejsediarre |
| US20040185055A1 (en) | 2001-03-19 | 2004-09-23 | Glenn Gregory M | Transcutaneous immunostimulation |
| GB0123580D0 (en) | 2001-10-01 | 2001-11-21 | Glaxosmithkline Biolog Sa | Vaccine |
| GB0123756D0 (en) | 2001-10-03 | 2001-11-21 | King S College London | A novel chaperone-type of adjuvant for vaccination - Basic 1 |
| WO2003035836A2 (en) | 2001-10-24 | 2003-05-01 | Hybridon Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| FR2832423B1 (fr) | 2001-11-22 | 2004-10-08 | Vivalis | Systeme d'expression de proteines exogenes dans un systeme aviaire |
| US20050175588A1 (en) | 2002-02-11 | 2005-08-11 | Mosca Joseph D. | Production of a protein delivery system for in vivo therapeutic treatment |
| FR2836924B1 (fr) | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| US6919426B2 (en) | 2002-09-19 | 2005-07-19 | Amgen Inc. | Peptides and related molecules that modulate nerve growth factor activity |
| US7879338B2 (en) | 2003-07-21 | 2011-02-01 | Boyce Thompson Institute For Plant Research | Vectors and methods for immunization against norovirus using transgenic plants |
| EP1500699A1 (en) | 2003-07-22 | 2005-01-26 | Vivalis | Production of vaccinia virus with adherent or non adherent avian cell lines |
| US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
| EP1670824A2 (en) | 2003-09-24 | 2006-06-21 | Montana State University | Norovirus monoclonal antibodies and peptides |
| EP1528101A1 (en) | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
| ES2321212T3 (es) | 2004-05-18 | 2009-06-03 | Alphavax, Inc. | Vectores alfavirus derivados de tc-83, particulas y metodos antecentes de la invencion. |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| KR20080018176A (ko) | 2005-06-01 | 2008-02-27 | 다우 글로벌 테크놀로지스 인크. | 다가 바이러스 유사 입자 생산 방법 |
| WO2007081447A2 (en) | 2005-11-22 | 2007-07-19 | Novartis Vaccines And Diagnostics, Inc. | Norovirus and sapovirus antigens |
| EP1979485A2 (en) | 2006-01-31 | 2008-10-15 | The Board Of Trustees Of The Leland Stanford Junior University | Self-complementary parvoviral vectors, and methods for making and using the same |
| WO2009039229A2 (en) | 2007-09-18 | 2009-03-26 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
| ES2602610T3 (es) | 2007-05-31 | 2017-02-21 | Medigene Ag | Proteína estructural mutada de un parvovirus |
| CN101153341B (zh) * | 2007-09-21 | 2010-12-15 | 珠海市疾病预防控制中心 | 诺如病毒gⅱ型检测用引物、检测方法、检测试剂盒 |
| MX2010009738A (es) | 2008-03-03 | 2010-09-30 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de tlr. |
| US8877908B2 (en) | 2008-07-11 | 2014-11-04 | The Administrators Of The Tulane Educational Fund | Stimulus-responsive apta chelamers |
| WO2010017542A1 (en) * | 2008-08-08 | 2010-02-11 | Ligocyte Pharmaceuticals, Inc. | Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| ES2589852T3 (es) | 2008-09-17 | 2016-11-16 | Xencor Inc. | Anticuerpo específico para IgE |
| TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子 |
| MX2011005505A (es) | 2008-11-26 | 2011-09-01 | Amgen Inc | Variantes de polipeptidos receptores de activina iib y aplicaciones de estos. |
-
2011
- 2011-07-05 MX MX2013000163A patent/MX2013000163A/es unknown
- 2011-07-05 AU AU2011276328A patent/AU2011276328C1/en active Active
- 2011-07-05 US US13/808,157 patent/US20130171185A1/en not_active Abandoned
- 2011-07-05 CN CN201180042647.5A patent/CN103154242B/zh active Active
- 2011-07-05 EP EP16199523.8A patent/EP3153578A1/en not_active Ceased
- 2011-07-05 JP JP2013518791A patent/JP2013533745A/ja active Pending
- 2011-07-05 CA CA2804501A patent/CA2804501C/en active Active
- 2011-07-05 EP EP11735734.3A patent/EP2591097A1/en not_active Withdrawn
- 2011-07-05 WO PCT/US2011/042979 patent/WO2012006293A1/en not_active Ceased
-
2015
- 2015-11-19 US US14/946,324 patent/US10065994B2/en active Active
-
2016
- 2016-01-06 JP JP2016000962A patent/JP6351641B2/ja active Active
-
2018
- 2018-02-23 JP JP2018030649A patent/JP2018086020A/ja not_active Withdrawn
- 2018-08-02 US US16/053,399 patent/US10287324B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013533745A5 (enExample) | ||
| JP2011152137A5 (enExample) | ||
| JP2015119730A5 (enExample) | ||
| JP2014221052A5 (enExample) | ||
| JP2011182797A5 (enExample) | ||
| CN104781413B (zh) | 用于具有肺炎球菌血清型的荚膜多糖的生产方法 | |
| Norkiene et al. | Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast | |
| WO2021088825A1 (zh) | F基因型腮腺炎病毒减毒株及构建方法和应用 | |
| CN109601007A (zh) | 一种口蹄疫病毒样颗粒疫苗及其制备方法 | |
| CN107267532A (zh) | PEDV JS2008株全长感染性cDNA的构建方法及应用 | |
| CN103333849B (zh) | 金黄色葡萄球菌突变株及其制备方法和应用 | |
| CN105755015B (zh) | 表达鸡传染性法氏囊病毒病毒样颗粒的重组酵母菌株及其所表达的蛋白和用途 | |
| JP2023024998A5 (enExample) | ||
| CN111218477B (zh) | 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用 | |
| CN104404057B (zh) | 一种大鲵虹彩病毒病疫苗及制备方法和应用 | |
| Cantarella et al. | Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma | |
| CN105349562B (zh) | 表达猪细小病毒vp2蛋白的重组载体、重组菌及其应用 | |
| JP2014530609A5 (enExample) | ||
| CN104046586B (zh) | 一株基因工程菌及其在生产(2r,3r)-2,3-丁二醇中的应用 | |
| CN103993032A (zh) | 一种制备重组脊髓灰质炎病毒样颗粒的方法 | |
| Krammer et al. | Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis | |
| JP2015507472A5 (enExample) | ||
| CN106905434B (zh) | 一种包含蹄蝠肝炎病毒核心蛋白的重组融合蛋白及其制备方法和应用 | |
| KR100959145B1 (ko) | 인유두종바이러스 바이러스 유사 입자의 생산 및 정제 방법 | |
| CN103396975B (zh) | 基于载体pSVK的乙肝治疗性质粒DNA疫苗的发酵生产方法及其专用工程菌及高产发酵培养基 |